Drug Eluting Balloons Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Drug Eluting Balloons Market – Report Overview

Pacific Business Consulting’s “Drug Eluting Balloons Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Drug Eluting Balloons market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Drug Eluting Balloons market exceeded a valuation of over US$ xx Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 7.0% from 2023 to 2030. The market is expected to potentially surpass US$ xx Billion by 2030.

The drug-eluting balloon market is experiencing increased product demand due to various factors, with a key driver being the growing prevalence of heart diseases, encompassing both peripheral and coronary artery disease. According to the American Heart Association in 2022, global estimates indicated that in 2020, 244.1 million people were living with ischemic heart disease (IHD), also known as coronary heart or coronary artery disease. This condition was more prevalent in males, with 141.0 million cases, compared to 103.1 million in females. Furthermore, the British Heart Foundation in 2023 estimated that peripheral arterial (vascular) disease accounted for 110 million cases globally in 2019. As these diseases become more widespread, the demand for drug-eluting balloons, frequently used in their treatment and management, is expected to rise.

Drug-eluting balloons offer several advantages over drug-eluting stents in targeted drug delivery, making them increasingly utilized in angioplasty surgeries for various cardiovascular indications. These devices have demonstrated better angiographic and clinical outcomes compared to stents or open surgeries. The use of drug-coated balloons is particularly preferred for coronary disease due to their minimal side effects. Additionally, drug-coated balloon catheters, when used in minimally invasive procedures, are considered a preferable alternative to risky stent treatments for conditions like myocardial infarction.

Market participants actively contribute to product development to enhance their market presence. For example, in June 2023, Surmodics, Inc. received FDA approval for the SurVeil drug-coated balloon (DCB). Many businesses and key players in the field are working on creating technologically advanced peripheral drug-eluting balloons. For instance, BD (Becton, Dickinson, and Company) announced the initiation of enrollment in a first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB) in August 2022. This trial aims to evaluate the safety of the BD sirolimus DCB in treating peripheral arterial disease. In November 2020, Boston Scientific received FDA approval for the Ranger™ Drug-Coated Balloon, developed for treating patients with peripheral artery disease.

The increasing preference for minimally invasive procedures, the advantages of balloon catheters over drug-eluting stents, the growing elderly population, and other factors are expected to drive the demand for drug-eluting balloons in the coming years. Additionally, factors such as growing healthcare spending, particularly in emerging countries, increased product launches and approvals, and rising research and developmental activities by key players contribute to the overall growth of the drug-eluting balloon market during the forecast period from 2023-2030.

Leading players in the Drug Eluting Balloons segment, including B. Braun SE, Aachen Resonance Entwicklungsgesellschaft mbH, Biosensors International Group, Ltd., Eurocor GmbH, iVascular, Innvolution, Cardiovascular Systems, Inc., Genesis Medtech, Concept Medical, Cardionovum GmbH, Boston Scientific Corporation, BD, Terumo Corporation, Medtronic, Koninklijke Philips N.V., M.A. Med Alliance SA., Cook, Biotronik, SurModics Inc., are expected to play a crucial role in shaping the future landscape of Drug Eluting Balloons technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Drug Eluting Balloons market. It also delves into the analysis of present and prospective market competition within the global Drug Eluting Balloons market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Drug Eluting Balloons market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Drug Eluting Balloons market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Drug Eluting Balloons
   • Global Market Outlook: Drug Eluting Balloons
2. Competitive Intelligence Analysis: Drug Eluting Balloons
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Drug Eluting Balloons
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Drug Eluting Balloons
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Drug Eluting Balloons: Ten Major Market (10MM) – Market Analysis, By Product
   • Coronary Drug-eluting Balloon
   • Peripheral Drug-eluting Balloon
   • Others
9. Drug Eluting Balloons: Ten Major Market (10MM) – Market Analysis, By Technology
   • FreePac
   • TransPac
   • EnduraCoat
   • Others
10. Drug Eluting Balloons: Ten Major Market (10MM) – Market Analysis, By End User
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Other End Users
11. Drug Eluting Balloons: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

12. S. Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

13. K. Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

14. Germany Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

15. France Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

16. Italy Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

17. Spain Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

18. Japan Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

19. China Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

20. Australia Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

21. India Drug Eluting Balloons – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer